Teriparatide Completed Phase 4 Trials for Type 2 Diabetes Mellitus / Postmenopausal Osteoporosis Diagnostic

Indications	Status	Purpose	Phase
DBCOND0029752 (Type 2 Diabetes Mellitus) DBCOND0030339 (Postmenopausal Osteoporosis)	Completed	Diagnostic	4

clinicaltrials.gov Identifier	Title	Drugs
NCT03472846	MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis	Denosumab (DB06643) Teriparatide (DB06285)